Positive Options for Living with Lupus (21 page)

giousness of, 13, 23; definition

49–50, 104; diagnostic list of,

and name translation, 1, 21; dis-

52–55; dietary fat studies,

eases related to, 6, 89–91; future

84–85; on drug-induced lupus,

of, 111–119; genetics and,

101; and drug treatments, 67,

17–18, 24–28; history of, 1–2,

69, 105; on mixed connective

21–22; myths about, 2; statistics

tissue diseases (MCTDs), 90

and susceptibility, 14–18; sur-

Hughes’ syndrome.
See
antiphos-

vival rates of, 18–19, 20.
See also

pholipid syndrome (APS)

related topics

lymphocytes, 22, 45, 114–115

I

immigrants, 17–18

M

immunomodulators, 115

macular retinopathy, 67

immunosuppressive drugs, 71–73

major histocompatibility complex

infections, 74

(MHC), 27–28

inflammation: blood tests detecting,

malaise, 8–9

48–49; description and function,

malar (butterfly) rashes, 4, 9, 19, 39.

45–46; and diet, 85; drugs con-

See also
rashes

trolling, 60–64, 73, 86

medications.
See
drugs (medica-

insect bites, 53

tions); treatments, drug

methotrexate, 72, 73

J

migraines, 41, 53, 93

joint pain, 54, 96–99.
See also
arthri-Minnesota, University of, 119

tis; inflammation

miscarriages, 49, 53, 102

mixed connective tissue diseases

K

(MCTDs), 6, 90–91.
See also

Kaposi, Moritz, 21

arthritis

kidney disorders: during pregnancy,

monoclonal antibodies (MoAbs),

107; as symptom, 12, 41; and

114–115

treatments, 71–72, 73, 74,

mononucleosis, 9, 53

115–117

myalgic encephalitis (ME) (fibro-

Klemperer, Paul, 22

myalgia), 9, 92–94

mycophenolate mofetil (MMF), 73

L

lesions.
See
rashes

N

Libman-Sacks endocarditis (LSE),

National Institute of Environmental

94–96

Health Sciences, 26

Living with Lupus
(Blau), 32–33

National Institution of Arthritis and

LUMINA (Lupus in Minorities: Na-

Musculoskeletal and Skin Dis-

ture Versus Nurture), 18

eases (NIAMS), 18

POL text Q6 good.qxp 8/12/2006 7:39 PM Page 134

1 3 4

Po s i t i v e O pt i o n s fo r L i v i n g w i t h L u p u s
neonatal lupus, 19, 108

toms during, 8, 12; treatments

nephritis, 115.
See also
kidney dis-

during, 68, 72, 104–106.
See also

orders

antiphospholipid syndrome

neural-tube defects (NTD), 108

(APS)

neurological disorders, 41, 54, 71, 81

premenstrual problems, 54

newborns, 19, 25, 103, 106–109.
See

prolactin, 29–30, 112–113

also
pregnancy

nonsteroidal anti-inflammatory

R

drugs (NSAIDs), 60–64, 86

racial groups, 17–19, 28

randomized clinical trials (RCT),

O

57, 58–59

Osler, William, 22

rashes: and children, 19–20; descrip-

osteonecrosis, 96–98

tions and varieties of, 1, 4, 9–10,

osteoporosis, 30, 70, 75, 110

20, 39; and older patients, 20;

Oxford Handbook of Clinical Medicine

treatments for, 79, 80

(OHCM), 42

Raynaud’s phenomenon, 52, 90, 91

research and studies: children’s

P

symptoms, 19; dietary fat,

Paracelsus, 1, 21

84–85; ethnic variables, 18; gen-

patent formen ovale (PFO), 93

der differences, 20; hormone

Payne, Thomas, 21

levels, 29–30; new treatments,

pericarditis, 12, 20, 40, 94

112–119; oral contraception,

Petri, Michelle, 110

110; pets, 34–35; twins, 26;

pets, 33–35

viruses, 31

photosensitivity: aggravation of, 80,

respiratory system, 11–12, 40

88; and artificial lighting, 10, 79;

rheumatoid arthritis, 6, 61, 73

and drug treatments, 66; and

Rogerius, 1, 21

gender, 20; self-management of,

78–79; as symptom, 9, 10, 39

S

plasmapheresis, 116–117

Safety of Estrogens in Systemic Lu-

pleurisy, 12, 20, 40

pus Erythematosus National As-

polymyositis-dermatomyositis (PM-

sessment (SELENA), 110

DM), 6, 90

Schirmer’s test, 55

polypharmacy, 57–60

scleroderma, 90

Practical Summary of Skin Diseases

sclerosis, 6

(Cazenave), 21

self-help techniques: alternative

prasterone, 113–114

therapies, 87–88; depression,

preeclampsia, 107

81–83; diet, 84–87; fatigue,

pregnancy: and Anne, Queen of

77–78; for fibromyalgia, 94; skin

England, 102–103; antibody

symptoms and allergies, 78–80

problems during, 104; and in-

Sickly Stuarts, The
(Holmes), 102

herited predisposition, 25–26;

Sjögren’s (sicca) syndrome, 55, 80,

neonatal lupus, 19, 108; risks to

91–92

newborns, 103, 106–109; symp-

skin, 4, 79–80.
See also
rashes

POL text Q6 good.qxp 8/12/2006 7:39 PM Page 135

I n d e x

1 3 5

smoking, 35, 75

new developments in, 112–115;

social interaction, 82

nonsteroidal anti-inflammatory

stem cells and research, 117–118

drugs (NSAIDs), 60–64, 86; ran-

steroids, 60, 68–71, 75, 105

domized clinical trials (RCT) of,

sunscreens, 78

57, 58–59; treating side effects

supplements, 85, 87–88, 113

of, 74–75.
See also
self-help tech-

symptoms: ACR classification of,

niques

38–41, 51–52; and age, 20–21;

twins, 26–27

of children, 19–20; common,

5–6, 8–13; and gender, 20;

V

Hughes’ diagnostic list of, 52–55;

Vioxx, 62, 112

and medical history, 25.
See also

viruses, 30–33, 74

self-help techniques; treatments,

vision problems, as drug side effect,

drug

66–67

systemic lupus erythematosus.
See

vitamins, 85

lupus (systemic lupus erythe-

matosus)

W

weight loss, 84, 87

T

thrombosis, 20, 62, 75, 103–104

total lymphoid irradiation

(TLI), 116

treatments, drug: antimalarial, 21,

65–68, 105; antiphospholipid

syndrome and, 22, 75; cortico-

steroids, 60, 68–71; COX-2 in-

hibitors, 62; and diet, 85–87; for

fibromyalgia, 94; immunosup-

pressive, 71–73; interactions be-

tween multiple, 57–60, 61–62;

O R D E R F O R M

10% DISCOUNT on orders of $50 or more —

20% DISCOUNT on orders of $150 or more —

30% DISCOUNT on orders of $500 or more —

On cost of books for fully prepaid orders

NAME

ADDRESS

CITY/STATE

ZIP/POSTCODE

PHONE

COUNTRY (outside of U.S.)

TITLE QTY

PRICE

TOTAL

Positive Options for Living with Lupus

@ $12.95

Prices subject to change without notice

Please list other titles below:

@ $

@ $

@ $

@ $

@ $

@ $

@ $

@ $

Check here to receive our book catalog

❏

FREE

Shipping Costs

TOTAL

By Priority Mail: first book

Less discount @–––––%

(

)

$4.50, each additional

TOTAL COST OF BOOKS

book $1.00

–––––––––––

By UPS and to Canada:

Calif. residents add sales tax

–––––––––––

first book $5.50, each

additional book $1.50

Shipping & handling

–––––––––––

For rush orders and other

TOTAL ENCLOSED

countries call us at

(510) 865-5282

Please pay in U.S. funds only

❏ Check ❏ Money Order ❏ Visa ❏ MasterCard ❏ Discover Card #_______________________________ Exp. date _______

Signature _____________________________________________

Complete and mail to:

Hunter House Inc., Publishers

PO Box 2914, Alameda CA 94501-0914

Website: www.hunterhouse.com

Orders: (800) 266-5592 or email: [email protected] Phone (510) 865-5282 Fax (510) 865-4295

POL 8/2006

✃

• About the author
  
• Title Page
  
• Contents
  
• Dedication & Important Note
  
• Introduction
  
• Recognizing Lupus
  
• Who Develops Lupus, Where, and Why?
  
• The Causes of Lupus
  
• Diagnosing Lupus, Part I: In the Doctor's Office
  
• Diagnosing Lupus, Part 2: In the Laboratory
  
• Treating Lupus with Drugs, Part I
  
• Treating Lupus with Drugs, Part 2
  
• Do-It-Yourself Lupus Management
  
• Seven Lupus-Like Conditions
  
• Lupus and Pregnancy
  
• Fortelling the Future
  
• Glossary
  
• Further Reading
  
• Resources
  
• Index
  
• Order Form